Cleared Traditional

K220557 - MoistureMeterD Compact, LymphScanner

K220557 is an FDA 510(k) clearance for MoistureMeterD Compact, manufactured by Delfin Technologies, Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code OBH cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K220557 · Delfin Technologies, Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
88d
Days
Class 2
Risk

K220557 is an FDA 510(k) clearance for the MoistureMeterD Compact, LymphScanner. Classified as Monitor, Extracellular Fluid, Lymphedema, Extremity (product code OBH), Class II - Special Controls.

Submitted by Delfin Technologies, Ltd. (Kuopio, FI). The FDA issued a Cleared decision on May 27, 2022 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 870.2770 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Delfin Technologies, Ltd. devices

FDA 510(k) Submission Details - K220557

510(k) Number K220557 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 2022
Decision Date May 27, 2022
Days to Decision 88 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 131d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OBH Device Classification - Class 2, Special Controls

Product Code OBH Monitor, Extracellular Fluid, Lymphedema, Extremity
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
Definition Measure Impedances In Affected And Unaffected But Opposite Extremity To Periodically Monitor The Level Of Extracellular Fluid Or The Differences In Bioimpedance Between Opposing Extremities For Patients Who Have Been Previously Diagnosed With Unilateral Lymphedema (that Is, In One Affected Extremity)
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

F Care Systems USA (Dba: Delfin USA, LLC)
Patrick Danciu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OBH Monitor, Extracellular Fluid, Lymphedema, Extremity

All 9
Devices cleared under the same product code (OBH) and FDA review panel - the closest regulatory comparables to K220557.
MySOZO Software version 6.0.1.2 (SW version 6.0.1.2)
K253224 · ImpediMed Limited · Jan 2026
SOZO Pro
K230530 · ImpediMed Limited · May 2023
SOZO
K180126 · ImpediMed Limited · Apr 2018
SOZO
K172122 · ImpediMed Limited · Aug 2017
MoisturemeterD
K143310 · Delfin Technologies, Ltd. · Nov 2015
IMPEDIMED - BIS EXTRA CELLULAR FLUID ANALYSIS
K130338 · ImpediMed Limited · May 2013